Damora Therapeutics, Inc. (DMRA)
24.58
-0.17
(-0.69%)
USD |
NASDAQ |
Sep 16, 16:00
24.58
0.00 (0.00%)
After-Hours: 17:36
Damora Therapeutics Price to Book Value : 3.932 for Sept. 16, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 3.959 |
| September 14, 2026 | 4.541 |
| September 11, 2026 | 4.495 |
| September 10, 2026 | 4.293 |
| September 09, 2026 | 4.202 |
| September 08, 2026 | 4.666 |
| September 04, 2026 | 4.808 |
| September 03, 2026 | 4.479 |
| September 02, 2026 | 4.508 |
| September 01, 2026 | 4.501 |
| August 31, 2026 | 4.508 |
| August 28, 2026 | 4.639 |
| August 27, 2026 | 4.895 |
| August 26, 2026 | 4.861 |
| August 25, 2026 | 4.898 |
| August 24, 2026 | 4.848 |
| August 21, 2026 | 4.930 |
| August 20, 2026 | 4.848 |
| August 19, 2026 | 5.189 |
| August 18, 2026 | 5.087 |
| August 17, 2026 | 4.973 |
| August 14, 2026 | 4.965 |
| August 13, 2026 | 4.915 |
| August 12, 2026 | 4.959 |
| August 11, 2026 | 4.856 |
| Date | Value |
|---|---|
| August 10, 2026 | 4.725 |
| August 07, 2026 | 4.786 |
| August 06, 2026 | 4.780 |
| August 05, 2026 | 4.931 |
| August 04, 2026 | 4.802 |
| August 03, 2026 | 4.568 |
| July 31, 2026 | 4.637 |
| July 30, 2026 | 4.672 |
| July 29, 2026 | 4.532 |
| July 28, 2026 | 4.706 |
| July 27, 2026 | 4.709 |
| July 24, 2026 | 4.610 |
| July 23, 2026 | 4.666 |
| July 22, 2026 | 4.797 |
| July 21, 2026 | 5.277 |
| July 20, 2026 | 5.277 |
| July 17, 2026 | 5.035 |
| July 16, 2026 | 4.837 |
| July 15, 2026 | 4.951 |
| July 14, 2026 | 4.957 |
| July 13, 2026 | 4.479 |
| July 10, 2026 | 4.564 |
| July 09, 2026 | 4.923 |
| July 08, 2026 | 4.404 |
| July 07, 2026 | 4.799 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.626 |
| Alnylam Pharmaceuticals, Inc. | 23.65 |
| Anika Therapeutics, Inc. | 2.034 |
| Savara, Inc. | 7.349 |
| Vericel Corp. | 5.558 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0002 |
| Price | 24.58 |
| Earnings Yield | -507.7% |
| Market Cap | 1.518B |
| PEGY Ratio | -0.0002 |